Table IV.
TNM stage | No. of cases | Urinary DiAcSpm (%) | Serum CEA (%) | Serum CA19-9 (%) |
---|---|---|---|---|
0+I | 19 | 66.7a | 27.8 | 22.2 |
II | 32 | 71.9b | 46.9 | 15.7 |
III | 39 | 48.7a | 38.5 | 20.5 |
IV | 23 | 100.0a | 78.3 | 56.5 |
Total | 113 | 69.0b | 44.2 | 26.5 |
The positive rates of urinary DiAcSpm were significantly higher than those of serum CEA or CA19-9 in patients with all stages of CRC.
p<0.05,
p< 0.001.
DiAcSpm, N1,N12-diacetylspermine; CEA, carcinoembryonic antigen; CA19-9, cancer antigen 19-9; TNM, Tumor-Node-Metastasis.